Long-term monitoring of SARS-CoV-2 seroprevalence and variants in Ethiopia provides prediction for immunity and cross-immunity.
Humans
Ethiopia
/ epidemiology
COVID-19
/ epidemiology
SARS-CoV-2
/ immunology
Antibodies, Viral
/ blood
Seroepidemiologic Studies
Male
Adult
Female
Adolescent
Young Adult
Middle Aged
Child
Aged
Child, Preschool
Vaccination
COVID-19 Vaccines
/ immunology
Retrospective Studies
Reinfection
/ epidemiology
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
24 Apr 2024
24 Apr 2024
Historique:
received:
29
08
2023
accepted:
03
04
2024
medline:
25
4
2024
pubmed:
25
4
2024
entrez:
24
4
2024
Statut:
epublish
Résumé
Under-reporting of COVID-19 and the limited information about circulating SARS-CoV-2 variants remain major challenges for many African countries. We analyzed SARS-CoV-2 infection dynamics in Addis Ababa and Jimma, Ethiopia, focusing on reinfection, immunity, and vaccination effects. We conducted an antibody serology study spanning August 2020 to July 2022 with five rounds of data collection across a population of 4723, sequenced PCR-test positive samples, used available test positivity rates, and constructed two mathematical models integrating this data. A multivariant model explores variant dynamics identifying wildtype, alpha, delta, and omicron BA.4/5 as key variants in the study population, and cross-immunity between variants, revealing risk reductions between 24% and 69%. An antibody-level model predicts slow decay leading to sustained high antibody levels. Retrospectively, increased early vaccination might have substantially reduced infections during the delta and omicron waves in the considered group of individuals, though further vaccination now seems less impactful.
Identifiants
pubmed: 38658564
doi: 10.1038/s41467-024-47556-2
pii: 10.1038/s41467-024-47556-2
doi:
Substances chimiques
Antibodies, Viral
0
COVID-19 Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3463Subventions
Organisme : Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research)
ID : MoKoCo19; 01KI20271 and FitMultiCell; 031L0159C and INSIDe; 031L0297A
Organisme : EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020)
ID : ORCHESTRA; 101016167
Organisme : Volkswagen Foundation (VolkswagenStiftung)
ID : E2; 99 450
Informations de copyright
© 2024. The Author(s).
Références
Gudina, E. K. et al. Seroepidemiology and model-based prediction of SARS-CoV-2 in Ethiopia: longitudinal cohort study among front-line hospital workers and communities. Lancet Glob. Health 9, e1517–e1527 (2021).
doi: 10.1016/S2214-109X(21)00386-7
pubmed: 34678196
pmcid: 8525918
Mulu, A. et al. The challenges of COVID-19 testing in Africa: the Ethiopian experience. Pan Afr. Med. J. 38, 6 (2021).
doi: 10.11604/pamj.2021.38.6.26902
pubmed: 33520075
pmcid: 7825374
Lamptey, E., Senkyire, E. K., Benita, D. A. & Boakye, E. O. COVID-19 vaccines development in Africa: a review of current situation and existing challenges of vaccine production. Clin. Exp. Vaccin. Res. 11, 82–88 (2022).
doi: 10.7774/cevr.2022.11.1.82
Sahile, A. T., Gizaw, G. D., Mgutshini, T., Gebremariam, Z. M. & Bekele, G. E. COVID-19 Vaccine Acceptance Level in Ethiopia: A Systematic Review and Meta-Analysis. Can. J. Infect. Dis. Med. Microbiol. 2022, 2313367 (2022).
doi: 10.1155/2022/2313367
pubmed: 36061634
pmcid: 9436617
Tonen-Wolyec, S., Mbumba Lupaka, D.-M., Batina-Agasa, S., Mbopi Keou, F.-X. & Bélec, L. Review of authorship for COVID-19 research conducted during the 2020 first-wave epidemic in Africa reveals emergence of promising African biomedical research and persisting asymmetry of international collaborations. Trop. Med. Int. Health 27, 137–148 (2022).
doi: 10.1111/tmi.13717
pubmed: 34984771
Abagero, A. et al. A Review of COVID-19 Response Challenges in Ethiopia. Int. J. Environ. Res. Public Health 19, 11070 (2022).
doi: 10.3390/ijerph191711070
pubmed: 36078785
pmcid: 9518440
Gelanew, T. et al. High seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers. BMC Infect. Dis. 22, 261 (2022).
doi: 10.1186/s12879-022-07247-z
pubmed: 35296265
pmcid: 8926102
Abdella, S. et al. Prevalence of SARS-CoV-2 in urban and rural Ethiopia: Randomized household serosurveys reveal level of spread during the first wave of the pandemic. EClinicalMedicine 35, 100880 (2021).
doi: 10.1016/j.eclinm.2021.100880
pubmed: 34124630
pmcid: 8176122
Sisay, A. et al. Molecular Epidemiology and Diversity of SARS-CoV-2 in Ethiopia, 2020-2022. Genes 14, 705 (2023).
doi: 10.3390/genes14030705
pubmed: 36980977
pmcid: 10047986
Olbrich, L. et al. Head-to-head evaluation of seven different seroassays including direct viral neutralisation in a representative cohort for SARS-CoV-2. J. Gen. Virol. 102, 001653 (2021).
doi: 10.1099/jgv.0.001653
pubmed: 34623233
pmcid: 8604188
Le Gleut, R. et al. The representative COVID-19 cohort Munich (KoCo19): from the beginning of the pandemic to the Delta virus variant. BMC Infect. Dis. 23, 1–15 (2023).
doi: 10.1186/s12879-023-08435-1
Gangavarapu, K. et al. Outbreak.info genomic reports: scalable and dynamic surveillance of SARS-CoV-2 variants and mutations. Nat. Methods 20, 512–522 (2023).
Tsueng, G. et al. Outbreak.info Research Library: a standardized, searchable platform to discover and explore COVID-19 resources. Nat. Methods 20, 536–540 (2023).
doi: 10.1038/s41592-023-01770-w
pubmed: 36823331
pmcid: 10393269
Mohammadi-Kambs, M., Hölz, K., Somoza, M. M. & Ott, A. Hamming Distance as a Concept in DNA Molecular Recognition. ACS Omega 2, 1302–1308 (2017).
doi: 10.1021/acsomega.7b00053
pubmed: 28474009
pmcid: 5410656
Kindhi, B. A., Hendrawan, M. A., Purwitasari, D., Sardjono, T. A. & Purnomo, M. H. Distance-based pattern matching of DNA sequences for evaluating primary mutation. in 2017 2nd International conferences on Information Technology, Information Systems and Electrical Engineering (ICITISEE) 310–314. https://doi.org/10.1109/ICITISEE.2017.8285518 (2017).
Chen, Z., Bancej, C., Lee, L. & Champredon, D. Antigenic drift and epidemiological severity of seasonal influenza in Canada. Sci. Rep. 12, 15625 (2022).
doi: 10.1038/s41598-022-19996-7
pubmed: 36115880
pmcid: 9482630
Ethiopia launches a COVID-19 vaccination campaign targeting the 12 years and above population. WHO | Regional Office for Africa https://www.afro.who.int/news/ethiopia-launches-covid-19-vaccination-campaign-targeting-12-years-and-above-population .
Ma, K. C. et al. Trends in Laboratory-Confirmed SARS-CoV-2 Reinfections and Associated Hospitalizations and Deaths Among Adults Aged ≥18 Years − 18 U.S. Jurisdictions, September 2021-December 2022. MMWR Morb. Mortal. Wkly. Rep. 72, 683–689 (2023).
doi: 10.15585/mmwr.mm7225a3
pubmed: 37347715
pmcid: 10328471
Habenom, H., Aychluh, M., Suthar, D. L., Al-Mdallal, Q. & Purohit, S. D. Modeling and analysis on the transmission of covid-19 Pandemic in Ethiopia. Alex. Eng. J. 61, 5323–5342 (2022).
doi: 10.1016/j.aej.2021.10.054
Nkwayep, C. H., Bowong, S., Tsanou, B., Alaoui, M. A. A. & Kurths, J. Mathematical modeling of COVID-19 pandemic in the context of sub-Saharan Africa: a short-term forecasting in Cameroon and Gabon. Math. Med. Biol. 39, 1–48 (2022).
doi: 10.1093/imammb/dqab020
pubmed: 35045180
Akuka, P. N. A., Seidu, B. & Bornaa, C. S. Mathematical Analysis of COVID-19 Transmission Dynamics Model in Ghana with Double-Dose Vaccination and Quarantine. Comput. Math. Methods Med. 2022, 7493087 (2022).
doi: 10.1155/2022/7493087
pubmed: 35928979
pmcid: 9344484
Khan, M. A. & Atangana, A. Mathematical modeling and analysis of COVID-19: A study of new variant Omicron. Phys. A 599, 127452 (2022).
doi: 10.1016/j.physa.2022.127452
Li, X.-P. et al. Assessing the potential impact of COVID-19 Omicron variant: Insight through a fractional piecewise model. Results Phys. 38, 105652 (2022).
doi: 10.1016/j.rinp.2022.105652
pubmed: 35663799
pmcid: 9150900
Wangari, I. M. et al. Mathematical Modelling of COVID-19 Transmission in Kenya: A Model with Reinfection Transmission Mechanism. Comput. Math. Methods Med. 2021, 5384481 (2021).
doi: 10.1155/2021/5384481
pubmed: 34777563
pmcid: 8578696
Oke, A. S., Bada, O. I., Rasaq, G. & Adodo, V. Mathematical analysis of the dynamics of COVID-19 in Africa under the influence of asymptomatic cases and re-infection. Math. Methods Appl. Sci. 45, 137–149 (2022).
doi: 10.1002/mma.7769
pubmed: 34908633
Stein, C. et al. Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis. Lancet 401, 833–842 (2023).
doi: 10.1016/S0140-6736(22)02465-5
Altarawneh, H. N. et al. Protection against the Omicron Variant from Previous SARS-CoV-2 Infection. N. Engl. J. Med. 386, 1288–1290 (2022).
doi: 10.1056/NEJMc2200133
pubmed: 35139269
Van Elslande, J. et al. Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection. Diagn. Microbiol. Infect. Dis. 103, 115659 (2022).
doi: 10.1016/j.diagmicrobio.2022.115659
pubmed: 35278794
pmcid: 8837483
Iversen, K. et al. Seroprevalence of SARS-CoV-2 antibodies and reduced risk of reinfection through 6 months: a Danish observational cohort study of 44 000 healthcare workers. Clin. Microbiol. Infect. 28, 710–717 (2022).
doi: 10.1016/j.cmi.2021.09.005
pubmed: 34543759
Quick, J. nCoV-2019 sequencing protocol v2 (GunIt) v2 https://doi.org/10.17504/protocols.io.bdp7i5rn (2020).
Li, H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv [q-bio.GN] (2013).
Grubaugh, N. D. et al. An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar. Genome Biol. 20, 8 (2019).
doi: 10.1186/s13059-018-1618-7
pubmed: 30621750
pmcid: 6325816
O’Toole, Á. et al. Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool. Virus Evol. 7, veab064 (2021).
doi: 10.1093/ve/veab064
pubmed: 34527285
pmcid: 8344591
Hadfield, J. et al. Nextstrain: real-time tracking of pathogen evolution. Bioinformatics 34, 4121–4123 (2018).
doi: 10.1093/bioinformatics/bty407
pubmed: 29790939
pmcid: 6247931
Raimúndez, E. et al. COVID-19 outbreak in Wuhan demonstrates the limitations of publicly available case numbers for epidemiological modeling. Epidemics 34, 100439 (2021).
doi: 10.1016/j.epidem.2021.100439
pubmed: 33556763
pmcid: 7845523
Hucka, M. et al. The Systems Biology Markup Language (SBML): Language Specification for Level 3 Version 2 Core Release 2. J. Integr. Bioinform. 16, 20190021 (2019).
pubmed: 31219795
pmcid: 6798823
Fröhlich, F. et al. AMICI: high-performance sensitivity analysis for large ordinary differential equation models. Bioinformatics 37, 3676–3677 (2021).
doi: 10.1093/bioinformatics/btab227
pubmed: 33821950
pmcid: 8545331
Schälte, Y. et al. pyPESTO: A modular and scalable tool for parameter estimation for dynamic models. Bioinformatics 39, btad711 (2023).
Schmiester, L. et al. PEtab-Interoperable specification of parameter estimation problems in systems biology. PLoS Comput. Biol. 17, e1008646 (2021).
doi: 10.1371/journal.pcbi.1008646
pubmed: 33497393
pmcid: 7864467
Leinonen, R., Sugawara, H. & Shumway, M., International Nucleotide Sequence Database Collaboration. The sequence read archive. Nucleic Acids Res 39, D19–D21 (2011).
doi: 10.1093/nar/gkq1019
pubmed: 21062823